Business
DRI Healthcare Trust Announces Closing of US$250 Million of Senior Secured Notes
DRI Healthcare Trust Announces Closing of US$250 Million of Senior Secured Notes Canada N...
About this update from Dri Healthcare Trust
[{"type":"text","content":"\n\n\nDRI Healthcare Trust Announces Closing of US$250 Million of Senior Secured Notes\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCanada NewsWire\n\n\nTORONTO, March 25, 2026 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (\"DRI Healthcare\") is pleased to announce that its subsidiary, DRI Healthcare LP (the \"Issuer\"), has successfully closed its previously announced private placement offering consisting of two tranches of senior secured notes (together, the \"Notes\"):\n\n\n\n\n\n\n\nUS$106 million aggregate principal amount of 5.35% Senior Secured Notes due March 24, 2031;US$144 million aggregate principal amount of 5.65% Senior Secured Notes due March 24, 2033.Interest on the Notes is payable semi-annually, and the Notes rank pari passu with the Issuer's existing amended and restated credit agreement and are secured by substantially all the assets of DRI Healthcare and its subsidiaries. The net proceeds of this offering are intended to be used to repay outstanding debt, pay related fees and expenses and for general corporate purposes.The Notes and the guarantees thereof have not been registered under the Securities Act of 1933, as amended (the \"Securities Act\"), or any state securities laws nor their distribution qualified under the Securities Act (Ontario) or the securities laws of any other Canadian province or territory. The Notes and the related guarantees were offered and sold only to qualified institutional buyers in reliance on Rule 144A under the Securities Act or, outside the United States, to persons other than \"U.S. persons\" in compliance with Regulation S under the Securities Act.This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such an offer, solicitation, or sale would be unlawful.About DRI HealthcareDRI Healthcare is a pioneer in global pharmaceutical royalty monetization. Since our founding in 1989, we have deployed more than $3.0 billion, acquiring more than 75 royalties on 50-plus drugs...